TheJobsMapAbyssinia Biologics jobs and careers
Portsmouth, NH, United States
About Abyssinia Biologics
Abyssinia is altering the world's understanding of Alzheimer's Disease from diagnostic assays with the potential for early diagnosis to treatment approaches addressing novel disease causes. Abyssinia's lead candidate ABY-71A1 is a IgG1 mAb with a high specificity for toxic soluble amyloid oligomers, which is backed up by ourcompanion diagnostic assay for soluble amyloid in plasma & CSF. Abyssinia was founded in 2017.
Founded in 2017 by Noah Ullman and Trebor R. Lawton.
- Founded
- 2017
- Employees
- 1 to 10
- Total funding
- $17K
- Headquarters
- Portsmouth
Leadership
The top of Abyssinia Biologics's org chart, with how many people report into each leader.
Trebor R. Lawton
Co-Founder
8 reports
Eric Yuen Md
Clinical Development
4 reports
Saira Ramasastry
Corporate Strategy
2 reports
Board
Peter N. Laivins
Advisor
Enchi Liu
Advisor
Rajnish Kaushik
Advisor
Mark Matijevic
Advisor
Keith Jansen
Advisor
Larry Jasinski
Advisor
Jobs at Abyssinia Biologics
No open positions right now. Explore more companies on TheJobsMap.